Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value ($000): $2,474,055 (100.0% shares, 0.0% debt)

Holdings (36)

ABIOMED INC 12.9%
Value ($000) $318,835 Shares 708,917 Est. Cost $32.04 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 10.0%
Value ($000) $247,218 Shares 2,549,431 Est. Cost $79.79 Unrealized +25.1%
UTHR UNITED THERAPEUTICS CORP DEL 8.4%
Value ($000) $207,835 Shares 1,625,234 Est. Cost $88.73 Unrealized +39.4%
STAA STAAR SURGICAL CO 6.8%
Value ($000) $169,035 Shares 3,521,565 Est. Cost $8.00 Unrealized +411.6%
ALEXION PHARMACEUTICALS INC 6.7%
Value ($000) $166,840 Shares 1,200,201 Est. Cost $121.26 Unrealized
CLOVIS ONCOLOGY INC 6.2%
Value ($000) $153,342 Shares 5,221,026 Est. Cost $51.30 Unrealized
INSM INSMED INC 6.0%
Value ($000) $148,764 Shares 7,357,283 Est. Cost $16.87 Unrealized +34.1%
SAGE THERAPEUTICS INC 4.8%
Value ($000) $118,703 Shares 840,372 Est. Cost $48.02 Unrealized
IMMUNOMEDICS INC 4.2%
Value ($000) $104,437 Shares 5,013,764 Est. Cost $11.93 Unrealized
VNDA VANDA PHARMACEUTICALS INC 3.9%
Value ($000) $95,373 Shares 4,155,670 Est. Cost $8.70 Unrealized +134.6%
WRIGHT MED GROUP N V 3.2%
Value ($000) $80,025 Shares 2,757,587 Est. Cost $23.42 Unrealized
KARYOPHARM THERAPEUTICS INC 3.2%
Value ($000) $79,416 Shares 4,663,324 Est. Cost $18.85 Unrealized
FOLD AMICUS THERAPEUTICS INC 3.1%
Value ($000) $76,967 Shares 6,366,147 Est. Cost $6.67 Unrealized +109.5%
EPIZYME INC 3.0%
Value ($000) $73,205 Shares 6,906,158 Est. Cost $15.12 Unrealized
AMAG PHARMACEUTICALS INC 2.7%
Value ($000) $67,610 Shares 3,380,506 Est. Cost $29.26 Unrealized
ALGN ALIGN TECHNOLOGY INC 2.3%
Value ($000) $57,825 Shares 147,807 Est. Cost $98.66 Unrealized +274.0%
MOMENTA PHARMACEUTICALS INC 1.9%
Value ($000) $48,222 Shares 1,833,532 Est. Cost $14.12 Unrealized
CELGENE CORP 1.6%
Value ($000) $38,415 Shares 429,267 Est. Cost $95.03 Unrealized
AIMMUNE THERAPEUTICS INC 1.5%
Value ($000) $37,694 Shares 1,381,759 Est. Cost $23.79 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 1.4%
Value ($000) $34,964 Shares 1,684,180 Est. Cost $29.54 Unrealized -46.7%
SHIRE PLC 1.4%
Value ($000) $34,938 Shares 192,738 Est. Cost $197.13 Unrealized
ALDER BIOPHARMACEUTICALS INC 1.2%
Value ($000) $30,854 Shares 1,853,101 Est. Cost $11.48 Unrealized
EXAS EXACT SCIENCES CORP 1.0%
Value ($000) $24,727 Shares 313,320 Est. Cost $13.61 Unrealized +379.0%
PRTA PROTHENA CORP PLC 0.6%
Value ($000) $14,431 Shares 1,103,325 Est. Cost $32.98 Unrealized -56.2%
GILD GILEAD SCIENCES INC 0.5%
Value ($000) $13,581 Shares 175,900 Est. Cost $62.02 Unrealized -8.4%
RIGEL PHARMACEUTICALS INC 0.5%
Value ($000) $12,731 Shares 3,966,087 Est. Cost $3.40 Unrealized
DICERNA PHARMACEUTICALS INC 0.3%
Value ($000) $7,644 Shares 500,913 Est. Cost $5.39 Unrealized
ALIMERA SCIENCES INC 0.1%
Value ($000) $2,954 Shares 3,013,793 Est. Cost $4.88 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value ($000) $2,325 Shares 1,162,473 Est. Cost $4.37 Unrealized
ZOGENIX INC 0.1%
Value ($000) $1,463 Shares 29,500 Est. Cost $13.36 Unrealized
CYTK CYTOKINETICS INC 0.0%
Value ($000) $1,218 Shares 123,686 Est. Cost $6.71 Unrealized +19.5%
TREVENA INC 0.0%
Value ($000) $724 Shares 341,300 Est. Cost $2.30 Unrealized
SOPHIRIS BIO INC 0.0%
Value ($000) $689 Shares 247,000 Est. Cost $2.60 Unrealized
IDERA PHARMACEUTICALS INC 0.0%
Value ($000) $686 Shares 77,044 Est. Cost $8.90 Unrealized
MELINTA THERAPEUTICS INC 0.0%
Value ($000) $200 Shares 50,689 Est. Cost $15.80 Unrealized
HISTOGENICS CORP 0.0%
Value ($000) $165 Shares 302,922 Est. Cost $11.00 Unrealized